TR-1: S tandard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i |
||||||
|
||||||
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : |
IMI plc No. 714275 LEI: 2138002W9Q21PF751R30 |
|||||
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) |
||||||
Non-UK issuer |
|
|||||
2. Reason for the notification (please mark the appropriate box or boxes with an "X") |
||||||
An acquisition or disposal of voting rights |
X |
|||||
An acquisition or disposal of financial instruments |
|
|||||
An event changing the breakdown of voting rights |
|
|||||
Other (please specify)iii: |
|
|||||
3. Details of person subject to the notification obligation iv |
||||||
Name |
American Century Investment Management, Inc., aggregate of delegated voting rights on behalf of multiple managed portfolios. |
|||||
City and country of registered office (if applicable) |
Kansas City, MO, USA |
|||||
4. Full name of shareholder(s) (if different from 3.) v |
||||||
Name |
|
|||||
City and country of registered office (if applicable) |
|
|||||
5. Date on which the threshold was crossed or reached vi : |
18/05/2020 |
|||||
6. Date on which issuer notified (DD/MM/YYYY): |
19/05/2020 |
|||||
7. Total positions of person(s) subject to the notification obligation |
||||||
|
% of voting rights attached to shares (total of 8. A) |
% of
voting rights through
financial instruments |
Total of both in % (8.A + 8.B) |
Total number of voting rights of issuer vii |
||
Resulting situation on the date on which threshold was crossed or reached |
Below 5% |
0% |
Below 5% |
272,210,381 |
||
Position of previous notification (if applicable) |
5.05% |
0% |
5.05% |
|
||
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii |
|||||||||
A: Voting rights attached to shares |
|||||||||
Class/type of ISIN code (if possible) |
Number of voting rights ix |
% of voting rights |
|||||||
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
||||||
GB00BGLP8L22 |
|
Below 5% |
|
Below 5% |
|||||
US44969D2071 |
|
Below 5% |
|
Below 5% |
|||||
|
|
|
|
|
|||||
SUBTOTAL 8. A |
Below 5% |
Below 5% |
|||||||
|
|||||||||
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) |
|||||||||
Type of financial instrument |
Expiration |
Exercise/ |
Number of voting rights that may be acquired if the instrument is exercised/converted. |
% of voting rights |
|||||
|
|
|
|
|
|||||
|
|
|
|
|
|||||
|
|
|
|
|
|||||
|
|
SUBTOTAL 8. B 1 |
|
|
|||||
|
|||||||||
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) |
|||||||||
Type of financial instrument |
Expiration |
Exercise/ |
Physical or cash settlement xii |
Number of voting rights |
% of voting rights |
||||
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
|
|
SUBTOTAL 8.B.2 |
|
|
||||
|
|||||||||
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") |
||||
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii |
|
|||
Full
chain of controlled undertakings through which the voting rights and/or the |
X |
|||
Name xv |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
|
Stowers Institute for Medical Research |
|
|
|
|
American Century Companies, Inc. |
|
|
|
|
American Century Investment Management, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
10. In case of proxy voting, please identify: |
||||
Name of the proxy holder |
|
|||
The number and % of voting rights held |
|
|||
The date until which the voting rights will be held |
|
|||
|
||||
11. Additional information xvi |
||||
In reference to item 9, the shares detailed are managed by American Century Investment Management, Inc. ("ACIM"), a discretionary investment management entity, on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to ACIM. Neither Stowers Institute for Medical Research nor American Century Companies, Inc. own shares of IMI plc. This disclosure is to reflect the fact that the voting rights held indirectly by ACIM has dropped below the 5% notifiable threshold due to trading on 18 May 2020. |
||||
Place of completion |
Kansas City, MO, USA |
Date of completion |
19/05/2020 |